Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study
Crossref DOI link: https://doi.org/10.1038/s41598-018-21884-y
Published Online: 2018-02-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Hsin-Yi
Lin, Shin-Yi
Cheng, Shou-Hsia
Wang, Chi-Chuan http://orcid.org/0000-0002-4597-4859
Text and Data Mining valid from 2018-02-22
Version of Record valid from 2018-02-22
Article History
Received: 30 May 2017
Accepted: 12 February 2018
First Online: 22 February 2018
Competing Interests
: The authors declare no competing interests.